Reading Time: 3 minutes COVID-19 continues to drive profound disruptions in clinical trials. According to a survey conducted by UBS, approximately 65% of trials have been impacted by COVID-19.[1] Additionally, site access has been reduced by 50%–80%. Sponsors’ reliance on CROs to adapt to these changes has never been higher. A CRO’s technology partner can play a major role […]
Article











